Brief: Innocan Pharma Reports Annual 2022 Results
18/04/2023 21:32
April 18 (Reuters) - Innocan Pharma Corp INNO.CD :
* INNOCAN PHARMA REPORTS ANNUAL 2022 RESULTS WITH USD 2.6M
IN
REVENUE
Source text for Eikon: ID:nCNW9jpMya
Further company coverage: INNO.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation